Antibacterial activity of paroxetine against Staphylococcus aureus and possible mechanisms of action

Future Microbiol. 2023 May:18:415-426. doi: 10.2217/fmb-2022-0232. Epub 2023 May 22.

Abstract

Aim: To evaluate the antibacterial activity of paroxetine alone and associated with oxacillin against isolates of methicillin-sensitive and -resistant Staphylococcus aureus. Materials & methods: The broth microdilution and checkerboard techniques were used, with investigation of possible mechanisms of action through flow cytometry, fluorescence microscopy and molecular docking, in addition to scanning electron microscopy for morphological analysis. Results: Paroxetine showed a MIC of 64 μg/ml and bactericidal activity, mostly additive interactions in combination with oxacillin, evidence of action on genetic material and membrane, morphological changes in microbial cells and influence on virulence factors. Conclusion: Paroxetine has antibacterial potential from the perspective of drug repositioning.

Keywords: Staphylococcus aureus; flow cytometry; molecular docking; paroxetine.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Humans
  • Methicillin-Resistant Staphylococcus aureus*
  • Microbial Sensitivity Tests
  • Molecular Docking Simulation
  • Oxacillin / pharmacology
  • Paroxetine / pharmacology
  • Staphylococcal Infections* / drug therapy
  • Staphylococcus aureus

Substances

  • Paroxetine
  • Anti-Bacterial Agents
  • Oxacillin